Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 25 April 1980:
Vol. 208. no. 4442, pp. 415 - 416
DOI: 10.1126/science.7189295

Articles

Science, Vol 208, Issue 4442, 415-416
Copyright © 1980 by American Association for the Advancement of Science


articles

Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate

CA McLaughlin, SM Schwartzman, BL Horner, GH Jones, JG Moffatt, JJ Nestor Jr, and D Tegg

A high incidence of tumor regression was observed in guinea pigs bearing transplantable, line-10 hepatocellular carcinomas when synthetic muramyl dipeptides combined with trehalose dimycolate in oil-in-water emulsions were injected directly into the tumors. These compounds are promising candidates to replace viable bacillus Calmette-Guerin in cancer immunotherapy in humans and animals.





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)